STOCKHOLM, Sweden, Oct. 1, 2009 (GLOBE NEWSWIRE) -- Diamyd Medical announces today that the company has signed an agreement with Inclinix Inc., North Carolina, for accelerated recruitment of children and adolescents recently diagnosed with type 1 diabetes in the U.S. Phase III study of the diabetes vaccine Diamyd(R).
